Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer

Despite advances in cancer chemotherapy, gastric cancer (GC) continues to have high recurrence rates and poor prognosis with limited treatment options. Understanding the etiology of GC and developing more effective, less harmful therapeutic approaches are vital and urgent. Therefore, this work descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesquita, Felipe Pantoja, Souza, Pedro Filho Noronha, da Silva, Emerson Lucena, Lima, Luina Benevides, de Oliveira, Lais Lacerda Brasil, Moreira-Nunes, Caroline Aquino, Zuercher, William J., Burbano, Rommel Mario Rodríguez, de Moraes, Maria Elisabete Amaral, Montenegro, Raquel Carvalho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501214/
https://www.ncbi.nlm.nih.gov/pubmed/36145589
http://dx.doi.org/10.3390/pharmaceutics14091841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501214/
https://www.ncbi.nlm.nih.gov/pubmed/36145589
http://dx.doi.org/10.3390/pharmaceutics14091841

Ejemplares similares